View item

US Department of Defense – Tick-Borne Disease Research Program (TBDRP) – Investigator-Initiated Research Award
Sponsor: US Department of Defense 		Closing Date: 25-Jun-2018
The TBDRP’s mission is to support research to understand the pathogenesis of Lyme disease and other tick-borne illnesses and to deliver innovative solutions to prevent, better diagnose, and treat their manifestations for the benefit of military Service members and the American public.

The FY18 TBDRP Investigator-Initiated Research Award (IIRA) intends to support highly rigorous, high-impact studies that have the potential to make important contributions to Lyme disease and other tick-borne diseases research, patient care, and/or quality of life. This award mechanism promotes a wide range of research from basic through translational, including preclinical studies in animal models or human subjects, as well as correlative studies associated with an existing clinical trial to establish proof-of-principle for further development in future studies. Applications should articulate how the proposed research is relevant to at least one of the FY18 TBDRP Focus Areas.

Eligibility
• Independent investigators at or above the level of Assistant Professor (or equivalent) are eligible to submit applications under this mechanism.

Key Mechanism Elements
• To fund highly rigorous, high-impact studies that have the potential to make important contributions to Lyme disease and/or other tick-borne diseases research, patient care, and/or quality of life.
• Applications should articulate both the short and long-term impact of the proposed research, including the potential impact of the research on reducing the public health burden of the disease being addressed.
• Preliminary or published data to support feasibility are required.
• Promotes any phase of research from basic through translational, including preclinical studies in animal models or human subjects, as well as correlative studies associated with an existing clinical trial to establish proof-of-principle for further development in future studies; however, clinical trials are not allowed.
• Preproposal is required; application submission is by invitation only.

Funding
• Maximum funding of USD $650,000 for direct costs (plus indirect costs)
• Maximum period of performance is 3 years.

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at http://cdmrp.army.mil/funding/tbdrp and http://cdmrp.army.mil/tbdrp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Pre-applications due to UQR&I: 11 June 2018
Pre-applications (mandatory) close with US Department of Defense: 25 June 2018
Invitation from U.S. Department of Defense to submit a full application: 13 August 2018
Invited full applications close with US Department of Defense: 27 September 2018

Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au. Interested applicants are strongly encouraged to make contact with the UQR&I international team (via internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: http://cdmrp.army.mil/funding/tbdrp

Return